Search filters

List of works by Kei Itagaki

Altered Serum Levels of Matrix Metalloproteinase-2, -9 in Response to Electroconvulsive Therapy for Mood Disorders

scientific article published on 23 February 2016

Decreased serum levels of thrombospondin-1 in female depressed patients

scientific article published on 27 November 2019

Factors associated with relapse after a response to electroconvulsive therapy in unipolar versus bipolar depression

scientific article published on 11 October 2016

Identification of Lysophosphatidic Acid Receptor 1 in Astroglial Cells as a Target for Glial Cell Line-derived Neurotrophic Factor Expression Induced by Antidepressants

scientific article published on 18 November 2016

PS127. Antidepressant amitriptyline activates matrix metalloproteinase in astroglial cells: involvement in glial cell line-derived neurotrophic factor expression

scientific article published on 27 May 2016

PS159. Altered serum levels of matrix metalloproteinase-2, -9 in response to electroconvulsive therapy for mood disorders.

scientific article published on 27 May 2016

Possible association between serum matrix metalloproteinase-9 (MMP-9) levels and relapse in depressed patients following electroconvulsive therapy (ECT).

scientific article published on 16 September 2017

Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder

scholarly article by Kei Itagaki et al published 1 April 2019 in The International Journal of Neuropsychopharmacology

Shared preventive factors associated with relapse after a response to electroconvulsive therapy in four major psychiatric disorders

scientific article published on 01 June 2019

The expression of glial cell line-derived neurotrophic factor mRNA by antidepressants involves matrix metalloproteinase-9 activation in rat astroglial cells

scientific article published on 24 September 2016